SCHEMBL23919324

SCHEMBL23919324

Cc1ccc2c(sc3ccccc32)c1N(c1ccccc1)c1ccc2ccc3c(N(c4ccccc4)c4c(C)ccc5c4sc4ccccc45)ccc4ccc1c2c43

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.35
L3MBTL1 Q9Y468 4/20 0.34
ATM Q13315 1/20 0.34
APP P05067 1/20 0.33
CHRM2 P08172 1/20 0.33
HTR1A P08908 1/20 0.33
ADRA2A P08913 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
CHRM1 P11229 1/20 0.33
MAOA P21397 1/20 0.33
DRD1 P21728 1/20 0.33
TBXA2R P21731 1/20 0.33
SLC6A2 P23975 1/20 0.33
APEX1 P27695 1/20 0.33
SLC6A4 P31645 1/20 0.33
ADRA1A P35348 1/20 0.33
OPRM1 P35372 1/20 0.33
DRD3 P35462 1/20 0.33
SLC6A3 Q01959 1/20 0.33
KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23919340 0.93 TNKS (0.33) MAPTL3MBTL1ATMAPPCHRM2
SCHEMBL23919322 0.93 L3MBTL1 (0.33) MAPTL3MBTL1ATMAPPCHRM2
SCHEMBL23919338 0.90 TNKS (0.33) MAPTL3MBTL1ATMALDH1A1CYP3A4
SCHEMBL23919325 0.90 MAPT (0.34) MAPTL3MBTL1ATMALDH1A1CYP3A4
SCHEMBL23919335 0.90 MAPT (0.35) MAPTL3MBTL1ATMALDH1A1CYP3A4
SCHEMBL23919420 0.90 MAPT (0.35) MAPTL3MBTL1ATMAPPCHRM2
SCHEMBL23919418 0.89 MAPT (0.33) MAPTL3MBTL1ATMAPPCHRM2
SCHEMBL23919417 0.89 TNKS (0.35) MAPTL3MBTL1ATMAPPCHRM2
SCHEMBL17036341 0.87 PRKDC (0.35) MAPTL3MBTL1ATMKCNH2ALDH1A1
SCHEMBL23919339 0.86 MAPT (0.32) MAPTPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320251-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE IDEMITSU KOSAN CO.,LTD. (JP) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320251-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE OLA1, TAS2R19, TMEM109 MAPT 2477/4885L3MBTL1 2341/4885ATM 1171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.